Prostate cancer screening reduces deathsBMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7145.1625c (Published 30 May 1998) Cite this as: BMJ 1998;316:1625
- Fred B Charatan
Routine screening for prostate cancer would significantly reduce mortality, according to the first large scale randomised trial.
Professor Fernand Labrie from Laval University in Quebec presented the trial's results at the annual meeting of the American Society of Clinical Oncology in Los Angeles last week. More than 46000 men aged between 45 and 80 years were randomly allocated to be screened or to receive no screening (standard medical practice). Men were invited by letter for screening.
At the first visit all the men in the screening group …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial